Please use this identifier to cite or link to this item:
|Title:||Aerosolized pentamidine for Pneumocystis pneumonia prophylaxis in renal transplant recipients – not as safe as one might think?|
|Authors:||Macesic, N;Urbancic, K;Ierino, F;Grayson, ML|
|Citation:||Antimicrobal Agents and Chemotherapy, 11 January 2016 epub|
|Abstract:||Outbreaks of Pneumocystis pneumonia have been described in renal transplant recipients. Aerosolized pentamidine is frequently used for prophylaxis in this setting. We report our experience of aerosolized pentamidine use in 56 renal transplant recipients and find high rates of adverse reactions in patients with chronic respiratory disease.|
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.